Omeros (OMER) FCF Margin Growth (5y) (2015 - 2026)
Omeros (OMER) FCF Margin Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Omeros |
737.87 Mn |
602.55 Mn |
9.31 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
4,456.00 |
| Sep 30, 2021 |
2,056.00 |
| Jun 30, 2021 |
3,220.00 |
| Mar 31, 2021 |
3,294.00 |
| Dec 31, 2020 |
7,635.00 |
| Sep 30, 2020 |
31,578.00 |
| Jun 30, 2020 |
24,377.00 |
| Mar 31, 2020 |
446,501.00 |
| Dec 31, 2019 |
865,719.00 |
| Sep 30, 2019 |
742,888.00 |
| Jun 30, 2019 |
3.39 Mn |
| Mar 31, 2019 |
1.11 Mn |
| Dec 31, 2018 |
10,238.00 |
| Sep 30, 2018 |
485,400.00 |
| Jun 30, 2018 |
483,006.00 |
| Mar 31, 2018 |
10,417.00 |
| Dec 31, 2017 |
80,297.00 |
| Sep 30, 2017 |
47,681.00 |
| Jun 30, 2017 |
53,646.00 |
| Mar 31, 2017 |
26,858.00 |
